T&R Biofab Co., Ltd. (246710) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for T&R Biofab Co., Ltd. (246710:KRX), powered by AI.

Current Price
₩2,100
P/E Ratio
-3.0
Market Cap
103.2B
Sector
Healthcare
What is the T&R Biofab Co., Ltd. stock price forecast?

T&R Biofab Co., Ltd. is currently trading at ₩2,100. View real-time AI analysis on Alpha Lenz.

What is T&R Biofab Co., Ltd. insider trading activity?

View the latest insider trading data for T&R Biofab Co., Ltd. on Alpha Lenz.

What is T&R Biofab Co., Ltd.'s P/E ratio?

T&R Biofab Co., Ltd.'s P/E ratio is -3.0.

T&R Biofab Co., Ltd.

KRX · 246710
₩2,100-65(-3.00%)Market closedKRX regular session 09:00–15:30 KST
Ask about T&R Biofab Co., Ltd.'s future dividend policy...
Alpha Chat Insight

T&R Biofab Co., Ltd. trades at a P/E of -3.0 (undervalued) with modest ROE of -147.8%. 3Y revenue CAGR of 67.3% highlights clear growth momentum.

Ask for details

Company Overview

T&R Biofab Co., Ltd. is a prominent player in the field of biotechnology, focusing on the development and commercialization of innovative regenerative medicine and bioengineering solutions. The company specializes in producing bio-printed tissues and organs, contributing significantly to advancements in medical science and treatment methodologies. By leveraging sophisticated 3D bioprinting technology, T&R Biofab aims to address critical healthcare needs and enhance patient outcomes around the globe. The firm's expertise extends to various applications, including drug testing and tissue implants, catering primarily to the healthcare and pharmaceutical industries. Situated in a rapidly evolving sector, T&R Biofab is integral to the ongoing transformation of personalized medicine and the medical device landscape, underscoring its importance in biotechnological and clinical advancements.

CEO윤원수
SectorHealthcare
IndustryMedical Devices
Employees93

Company Statistics

FY 2025

Profile

₩103,193,651,160Market Cap
₩26,967,256,190Revenue
47.66MShares Out
93Employees

Margins

25.51%Gross
-34.31%EBITDA
-31.78%Operating
-129.58%Pre-Tax
-129.58%Net

Valuation

-2.95P/E
4.47P/B
3.83EV/Sales
-13.51EV/EBITDA
-10.46P/FCF

Growth (CAGR)

67.34%Rev 3Yr
31.70%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-36.56%ROA
-147.79%ROE
-30.19%ROIC

Financial Health

₩7,760,524,310Cash & Cash Equivalents
₩61,875,558,440Net Debt
301.74%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

T&R Biofab Co., Ltd. (ticker: 246710) is a company listed on KRX in the Healthcare sector (Medical Devices). It has approximately 93 employees. Market cap is $103.2B.

The current price is ₩2,100 with a P/E ratio of -2.95x and P/B of 4.47x.

ROE is -147.79% and operating margin is -31.78%. Annual revenue is $27.0B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
T&R Biofab Co., Ltd. (246710) Stock Forecast 2026 ₩2,100 — Price, Financials & Analyst Targets | Alpha Lenz